Donepezil Hydrochloride (E2020) and Other Acetylcholinesterase Inhibitors

Title: Donepezil Hydrochloride (E2020) and Other Acetylcholinesterase Inhibitors

Volume: 7 Issue: 3

Author(s): Hachiro Sugimoto, Yoshiharu Yamanish, Youichi Iimura and Yoshiyuki Kawakami

Affiliation:

Keywords: donepezil hydrochloride, acetylcholinesterase inhibitors, alzheimer s disease, AChE inhibitors, cortical cholinergic neurotransmission, hepatotxic liability, physostigmine, cholineric enhancement therapy, ACh releasers, M1 M3 Receptor agonists, nicotinic agonists, velnacrine, amiridine, eptastigmine, galanthamine, rivastigmine, metrifonate, huperzine A, donepezil hydrocloride, anti AChE Activity, n alkyl analogs, molecular modeling, receptor dependent docking, crystal structure, BuChE, Brain acetylcholine concentrations, TAK 147, anti inflammatory agents, alzheimer s disease treatment, estrogen replacement therapy, anti oxidants, anti amyloid, galanin receptor antagonist

Abstract: A wide range of evidence shows that acetylcholinesterase (AChE) inhibitors can

Cite this article as:

Sugimoto Hachiro, Yamanish Yoshiharu, Iimura Youichi and Kawakami Yoshiyuki, Donepezil Hydrochloride (E2020) and Other Acetylcholinesterase Inhibitors, Current Medicinal Chemistry 2000; 7 (3) . https://dx.doi.org/10.2174/0929867003375191